X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-13 | PCRX | Gaugler Daryl | COO | S - Sale | $12.86 | -500 | 115,700 | 0% | -$6,430 | ||||||
2024-08-16 | PCRX | Bigal Marcelo | Dir | P - Purchase | $13.25 | +1,512 | 10,142 | +18% | +$20,034 | ||||||
2024-08-16 | PCRX | Brege Laura | Dir | P - Purchase | $12.81 | +1,000 | 17,552 | +6% | +$12,810 | ||||||
2024-08-14 | PCRX | Yang Michael J. | Dir | P - Purchase | $12.90 | +2,000 | 7,230 | +38% | +$25,800 | ||||||
2024-08-12 | PCRX | Lee Frank D. | CEO | P - Purchase | $12.10 | +8,264 | 107,784 | +8% | +$99,994 | ||||||
| A | 2024-08-12 | PCRX | Bigal Marcelo | Dir | P - Purchase | $12.01 | +3,400 | 8,630 | +65% | +$40,834 | |||||
2024-08-12 | PCRX | Froimson Mark | Dir | P - Purchase | $11.58 | +1,400 | 14,473 | +11% | +$16,212 | ||||||
2024-08-12 | PCRX | Bigal Marcelo | Dir | P - Purchase | $12.01 | +3,400 | 8,630 | +65% | +$40,834 | ||||||
2024-08-02 | PCRX | Slonin Jonathan | Chief Medical Officer | S - Sale | $20.05 | -945 | 94,307 | -1% | -$18,947 | ||||||
2024-07-02 | PCRX | Slonin Jonathan | Chief Medical Officer | S - Sale | $28.25 | -2,836 | 95,557 | -3% | -$80,117 | ||||||
2024-06-12 | PCRX | Riker Lauren | SVP, Finance | S - Sale | $28.72 | -3,970 | 38,075 | -9% | -$114,018 | ||||||
2024-06-11 | PCRX | Slonin Jonathan | Chief Medical Officer | S - Sale | $28.57 | -5,012 | 98,869 | -5% | -$143,193 | ||||||
2024-06-13 | PCRX | Gaugler Daryl | COO | S - Sale | $28.38 | -1,000 | 116,040 | -1% | -$28,380 | ||||||
| D | 2024-06-13 | PCRX | Hastings Paul J | Dir | S - Sale+OE | $28.38 | -880 | 12,724 | -6% | -$24,974 | |||||
2024-06-13 | PCRX | Williams Kristen | Chief Administrative Officer | S - Sale | $28.38 | -7,452 | 102,912 | -7% | -$211,488 | ||||||
| M | 2024-03-06 | PCRX | Pace Gary W | Dir | S - Sale | $30.64 | -119,323 | 22,127 | -84% | -$3,656,226 | |||||
2023-08-02 | PCRX | Winston Roy | Chief Medical Officer | S - Sale | $34.88 | -509 | 52,440 | -1% | -$17,751 | ||||||
2023-07-05 | PCRX | Riker Lauren Bullaro | SVP, Finance | S - Sale | $38.91 | -643 | 22,687 | -3% | -$25,019 | ||||||
| D | 2023-06-14 | PCRX | Williams Kristen Marie | Chief Administrative Officer | S - Sale+OE | $37.03 | -6,467 | 25,375 | -20% | -$239,473 | |||||
| D | 2023-06-14 | PCRX | Riker Lauren Bullaro | SVP, Finance | S - Sale+OE | $38.42 | -6,366 | 22,687 | -22% | -$244,606 | |||||
| D | 2023-06-08 | PCRX | Kronenfeld Mark A. | Dir | S - Sale+OE | $37.04 | -15,000 | 17,897 | -46% | -$555,600 | |||||
| M | 2023-06-06 | PCRX | Winston Roy | Chief Medical Officer | S - Sale | $38.42 | -3,636 | 41,356 | -8% | -$139,680 | |||||
| M | 2023-06-06 | PCRX | Williams Kristen Marie | Chief Administrative Officer | S - Sale | $38.42 | -2,658 | 20,892 | -11% | -$102,110 | |||||
| M | 2023-06-06 | PCRX | Stack David M | CEO, COB | S - Sale | $38.41 | -10,384 | 269,965 | -4% | -$398,885 | |||||
| M | 2023-06-06 | PCRX | Slonin Jonathan | Chief Clinical Officer | S - Sale | $38.42 | -961 | 36,323 | -3% | -$36,919 | |||||
| M | 2023-06-06 | PCRX | Riker Lauren Bullaro | SVP, Finance | S - Sale | $38.42 | -1,207 | 19,053 | -6% | -$46,369 | |||||
| M | 2023-06-06 | PCRX | Reinhart Charles A. III | CFO | S - Sale | $38.40 | -2,607 | 33,626 | -7% | -$100,106 | |||||
| M | 2023-06-06 | PCRX | Reinhardt Max | Pres, Rest of World | S - Sale | $38.42 | -2,153 | 29,225 | -7% | -$82,710 | |||||
| M | 2023-06-05 | PCRX | Molloy Anthony | Chief Lgl, Compliance Officer | S - Sale | $38.46 | -6,788 | 12,877 | -35% | -$261,059 | |||||
| M | 2023-06-06 | PCRX | McLoughlin Dennis | Chief Customer Officer | S - Sale | $38.42 | -2,071 | 38,115 | -5% | -$79,560 | |||||
2023-06-05 | PCRX | Hastings Paul J | Dir | S - Sale | $38.34 | -580 | 6,599 | -8% | -$22,237 | ||||||
| M | 2023-06-05 | PCRX | Gaugler Daryl | COO | S - Sale | $38.52 | -3,052 | 21,539 | -12% | -$117,571 | |||||
| M | 2023-06-06 | PCRX | Ellis Ronald J. Jr. | Chief Strategy Officer | S - Sale | $38.42 | -2,276 | 30,909 | -7% | -$87,435 | |||||
2023-06-05 | PCRX | Brege Laura | Dir | S - Sale | $38.74 | -600 | 9,547 | -6% | -$23,244 | ||||||
| D | 2023-05-31 | PCRX | Gaugler Daryl | COO | S - Sale+OE | $39.08 | -2,500 | 24,591 | -9% | -$97,700 | |||||
| D | 2023-05-15 | PCRX | Hastings Paul J | Dir | S - Sale+OE | $41.85 | -7,000 | 7,179 | -49% | -$292,950 | |||||
| D | 2023-05-11 | PCRX | Pace Gary W | Dir | S - Sale+OE | $41.78 | -5,015 | 139,675 | -3% | -$209,527 | |||||
| D | 2023-04-03 | PCRX | Brege Laura | Dir | S - Sale+OE | $40.72 | -7,000 | 10,147 | -41% | -$285,040 | |||||
| M | 2023-01-04 | PCRX | Molloy Anthony | Chief Lgl, Compliance Officer | S - Sale | $38.49 | -704 | 19,450 | -3% | -$27,094 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |